Abstract
ORAI1 is a pore subunit of the store-operated Ca2+ release-activated Ca2+ (CRAC) channel. To examine the physiological consequences of ORAI1 deficiency, we generated mice with targeted disruption of the Orai1 gene. The results of immunohistochemical analysis showed that ORAI1 is expressed in lymphocytes, skin, and muscle of wild-type mice and is not expressed in Orai1−/− mice. Orai1−/− mice with the inbred C57BL/6 background showed perinatal lethality, which was overcome by crossing them to outbred ICR mice. Orai1−/− mice were small in size, with eyelid irritation and sporadic hair loss resembling the cyclical alopecia observed in mice with keratinocyte-specific deletion of the Cnb1 gene. T and B cells developed normally in Orai1−/− mice, but B cells showed a substantial decrease in Ca2+ influx and cell proliferation in response to B-cell receptor stimulation. Naïve and differentiated Orai1−/− T cells showed substantial reductions in store-operated Ca2+ entry, CRAC currents, and cytokine production. These features are consistent with the severe combined immunodeficiency and mild extraimmunological symptoms observed in a patient with a missense mutation in human ORAI1 and distinguish the ORAI1-null mice described here from a previously reported Orai1 gene-trap mutant mouse which may be a hypomorph rather than a true null.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mcb.asm.org/ .
ACKNOWLEDGMENTS
We thank Hui Hu, Mark Sundrud, and Christine Patterson (Rajewsky lab) for help with experiments involving the generation of fetal liver chimeras, analysis of Tregs, and analysis of B-cell development, respectively. We also thank Jeffery L. Kutok from the specialized histopathology core at the Dana Farber/Harvard Cancer Center for his help with optimizing conditions for immunohistochemistry.
This work was supported by NIH and JDRF grants to A.R., an NIH grant and a March of Dimes Foundation grant to S.F., and NIH grants to M.P. and K.R. M.O. and Y.S. were supported by research fellowships from the Uehara Memorial Foundation.
P.G.H., S.F. and A.R. declare that they have competing financial interests.